首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Robust Diagnostic Genetic Testing Using Solution Capture Enrichment and a Novel Variant-Filtering Interface
【2h】

Robust Diagnostic Genetic Testing Using Solution Capture Enrichment and a Novel Variant-Filtering Interface

机译:使用溶液捕获富集和新型变异过滤接口进行强大的诊断基因测试

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Targeted hybridization enrichment prior to next-generation sequencing is a widespread method for characterizing sequence variation in a research setting, and is being adopted by diagnostic laboratories. However, the number of variants identified can overwhelm clinical laboratories with strict time constraints, the final interpretation of likely pathogenicity being a particular bottleneck. To address this, we have developed an approach in which, after automatic variant calling on a standard unix pipeline, subsequent variant filtering is performed interactively, using AgileExomeFilter and AgilePindelFilter (), tools designed for clinical scientists with standard desktop computers. To demonstrate the method's diagnostic efficacy, we tested 128 patients using (1) a targeted capture of 36 cancer-predisposing genes or (2) whole-exome capture for diagnosis of the genetically heterogeneous disorder primary ciliary dyskinesia (PCD). In the cancer cohort, complete concordance with previous diagnostic data was achieved across 793 variant genotypes. A high yield (42%) was also achieved for exome-based PCD diagnosis, underscoring the scalability of our method. Simple adjustments to the variant filtering parameters further allowed the identification of a homozygous truncating mutation in a presumptive new PCD gene, DNAH8. These tools should allow diagnostic laboratories to expand their testing portfolios flexibly, using a standard set of reagents and techniques.
机译:下一代测序之前的靶向杂交富集是表征研究背景中序列变异的一种广泛方法,目前已被诊断实验室采用。但是,所鉴定的变体数量可能使严格限制时间的临床实验室不堪重负,可能致病性的最终解释是一个特殊的瓶颈。为了解决这个问题,我们开发了一种方法,在这种方法中,在标准的unix管道上自动调用变体之后,使用为标准台式计算机设计用于临床科学家的工具AgileExomeFilter和AgilePindelFilter(),以交互方式执行后续变体过滤。为了证明该方法的诊断效力,我们使用(1)36种癌症易感基因的靶向捕获或(2)全外显子捕获对遗传异质性原发性睫状运动障碍(PCD)的诊断进行了测试,对128位患者进行了测试。在癌症队列中,在793个变异基因型中,与先前的诊断数据完全一致。基于外显子组的PCD诊断也获得了高收率(42%),这突出了我们方法的可扩展性。只需对变量过滤参数进行简单调整,就可以在推定的新PCD基因DNAH8中鉴定出纯合的截短突变。这些工具应允许诊断实验室使用一套标准的试剂和技术灵活地扩展其测试产品组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号